Orchard Therapeutics plc
ORTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $47,351 | $163,632 | $429,606 | $1,282,055 |
| - Cash | $68,424 | $55,912 | $55,135 | $19,053 |
| + Debt | $58,090 | $59,485 | $58,167 | $45,911 |
| Enterprise Value | $37,017 | $167,205 | $432,638 | $1,308,913 |
| Revenue | $6,986 | $483 | $2,595 | $2,513 |
| % Growth | 1,346.4% | -81.4% | 3.3% | – |
| Gross Profit | $4,553 | $257 | $1,738 | $1,708 |
| % Margin | 65.2% | 53.2% | 67% | 68% |
| EBITDA | -$8,079 | -$35,541 | -$148,378 | -$155,375 |
| % Margin | -115.6% | -7,358.4% | -5,717.8% | -6,182.8% |
| Net Income | -$7,883 | -$36,349 | -$151,979 | -$163,422 |
| % Margin | -112.8% | -7,525.7% | -5,856.6% | -6,503.1% |
| EPS Diluted | -0.61 | -2.93 | -15.28 | -17.53 |
| % Growth | 79.2% | 80.8% | 12.8% | – |
| Operating Cash Flow | -$75,987 | -$125,097 | -$126,274 | -$166,131 |
| Capital Expenditures | -$6,514 | -$3,235 | -$12,668 | -$4,367 |
| Free Cash Flow | -$82,501 | -$128,332 | -$138,942 | -$170,498 |